Utility of the plasma level of suPAR in monitoring risk of mortality during TB treatment.

<h4>Objective</h4>To investigate whether changes in the plasma level of soluble urokinase plasminogen activator receptor (suPAR) can be used to monitor tuberculosis (TB) treatment efficacy.<h4>Design</h4>This prospective cohort study included 278 patients diagnosed with activ...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Paulo Rabna, Andreas Andersen, Christian Wejse, Ines Oliveira, Victor Francisco Gomes, Maya Bonde Haaland, Peter Aaby, Jesper Eugen-Olsen
Format: article
Langue:EN
Publié: Public Library of Science (PLoS) 2012
Sujets:
R
Q
Accès en ligne:https://doaj.org/article/1b94c15df9c04928978ae2d95e2390e8
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!